[ Price : $8.95]
A regulatory consulting firm's report finds that FDA sharply increased enforcement activity against drugmakers and distributors in...[ Price : $8.95]
A legal update from ArentFox highlight several emerging regulatory and enforcement developments at FDA thatare expected to have si...[ Price : $8.95]
CBER director Vinay Prasads departure at the end of next month raises questions across the biotechnology sector about how the agen...[ Price : $8.95]
Former FDA official Grail Sipes says questions are emerging about the long-term impact of the Commissioners National Priority Vouc...[ Price : $8.95]
Insulet initiates a Class 1 device correction for certain lots of its Omnipod 5 Automated Insulin Delivery System pods after ident...[ Price : $8.95]
FDA approves Novartis Cosentyx (secukinumab) for treating adolescents aged 12 and older with moderate to severe Hidradenitis Suppu...[ Price : $8.95]
FDA expands the approved use of GSKs Arexvy, a respiratory syncytial virus accine that now includes the in adults aged 18 to 49 wh...[ Price : $8.95]
Eli Lilly issues a public warning that its testing found that compounded tirzepatide with vitamin B12 can produce an unknown impur...